A detailed history of Abich Financial Wealth Management LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 233 shares of NTLA stock, worth $3,331. This represents 0.01% of its overall portfolio holdings.

Number of Shares
233
Previous 72 223.61%
Holding current value
$3,331
Previous $1.61 Million 197.21%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$19.72 - $27.36 $3,174 - $4,404
161 Added 223.61%
233 $4.79 Million
Q2 2024

Aug 14, 2024

BUY
$20.02 - $27.22 $1,321 - $1,796
66 Added 1100.0%
72 $1.61 Million
Q1 2024

Jun 21, 2024

BUY
$23.82 - $32.8 $142 - $196
6 New
6 $165,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.09B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Abich Financial Wealth Management LLC Portfolio

Follow Abich Financial Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abich Financial Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abich Financial Wealth Management LLC with notifications on news.